copy

出典: meddic

  • n.
  • v.
  • コピーする、複写する、複製する
duplicateduplicationreplicareplicatereplicationreplicationalreplicativereproducereproduction

WordNet   license wordnet

「copy down as is; "The students were made to copy the alphabet over and over"」

WordNet   license wordnet

「a thing made to be similar or identical to another thing; "she made a copy of the designer dress"; "the clone was a copy of its ancestor"」

WordNet   license wordnet

「matter to be printed; exclusive of graphical materials」
written matter

WordNet   license wordnet

「material suitable for a journalistic account; "catastrophes make good copy"」

PrepTutorEJDIC   license prepejdic

「〈C〉『写す』,複写,(絵などの)模写,複製;謄本,抄本 / 〈C〉(同一書籍・雑誌・新聞などの)『部,冊』 / 〈U〉(印刷の)原稿,草稿 / 〈U〉ニュースねた,原稿材料 / …'を'『写す,複写する』,模写する / …'を'まねた / (…から)…'を'こっそり写す,盗作する《+『名』+『from』(『off』)+『名』》 / (…から…へ)『複写する』《+『from』(out of』)+『名』+『into』+『名』》 / (…を)こっそり写し取る《+『from』(『off』)+『名』》」

WordNet   license wordnet

「make a replica of; "copy that drawing"; "re-create a picture by Rembrandt"」
re-create

Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2013/05/07 04:07:01」(JST)

wiki en

[Wiki en表示]

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

英文文献

  • AN OPTIMIZED PROTOCOL FOR OVERPRODUCTION OF RECOMBINANT PROTEIN EXPRESSION IN Escherichia coli.
  • Bahreini E, Aghaiypour K, Abbasalipourkabir R, Goodarzi MT, Saidijam M, Safavieh SS.Author information a Research Center for Molecular Medicine , Hamadan University of Medical Sciences , Hamadan , Iran.AbstractThe gram-negative bacterium Escherichia coli (E. coli) offers a means for rapid, high-yield, and economical production of recombinant proteins. Here, a protocol for optimization of parameters involved in bacterial expression conditions is described. L-Asparaginase (ASNase II) was chosen as a model protein for our experiments. ASNase II gene (ansB) was cloned into the pAED4 plasmid and transformed into E. coli BL21pLysS (DE3)-competent cells. It was assumed that high cell density and high copy number of recombinant plasmid in the bacteria host could result in very high production of the recombinant protein. Circumstances for the overproduction of recombinant ASNase II including cell growth conditions, isopropyl β-D-1-thiogalactopyranoside (IPTG) level, ampicillin (Amp) concentration before and during IPTG induction, and cell density were optimized. Regarding the final optimization, overexpression of ASNase II was assessed on a large scale in LB medium. Periplasmic ASNase II was extracted using an alkaline lysis method. The extracted protein was purified by one-step DEAE-Sepharose fast-flow chromatography. ASNase II activity was considered an index for the protein expression. Applying the optimized practical protocol, protein production was significantly enhanced in comparison to the traditional IPTG induction method in the absence of a fermentor and can be applied for overexpression of other recombinant proteins.
  • Preparative biochemistry & biotechnology.Prep Biochem Biotechnol.2014 Jul 4;44(5):510-28. doi: 10.1080/10826068.2013.833116.
  • The gram-negative bacterium Escherichia coli (E. coli) offers a means for rapid, high-yield, and economical production of recombinant proteins. Here, a protocol for optimization of parameters involved in bacterial expression conditions is described. L-Asparaginase (ASNase II) was chosen as a model p
  • PMID 24219068
  • Detection rate and prognostic value of circulating tumor cells and circulating tumor DNA in metastatic uveal melanoma.
  • Bidard FC, Madic J, Mariani P, Piperno-Neumann S, Rampanou A, Servois V, Cassoux N, Desjardins L, Milder M, Vaucher I, Pierga JY, Lebofsky R, Stern MH, Lantz O.Author information Department of Medical Oncology, Institut Curie, Paris, France; Laboratory of Circulating Tumor Biomarkers, Institut Curie, Paris, France.AbstractCirculating tumor cells (CTCs) and circulating tumor DNA (ctDNA) have been recently investigated in several cancer types, but their respective clinical significance remains to be determined. In our prospective study, we compared the detection rate and the prognostic value of these two circulating biomarkers in patients with metastatic uveal melanoma. GNAQ/GNA11 mutations were characterized in archived tumor tissue. Using a highly sensitive and mutation-specific bidirectional pyrophosphorolysis-activated polymerization (bi-PAP) technique, GNAQ c.626A>T, GNAQ c.626A>C and GNA11 c.626A>T copy numbers were quantified in plasma from 12 mL of blood. CTCs were detected at the same time in 7.5 mL of blood by the CellSearch® technique. Patient characteristics and outcome were prospectively collected. CTCs (≥1) were detected in 12 of the 40 included patients (30%, range 1-20). Among the 26 patients with known detectable mutations, ctDNA was detected and quantified in 22 (84%, range 4-11,421 copies/mL). CTC count and ctDNA levels were associated with the presence of miliary hepatic metastasis (p = 0.004 and 0.03, respectively), with metastasis volume (p = 0.005 and 0.004) and with each other (p < 0.0001). CTC count and ctDNA levels were both strongly associated with progression-free survival (p = 0.003 and 0.001) and overall survival (p = 0.0009 and <0.0001). In multivariate analyses, ctDNA appeared to be a better prognostic marker than CTC. In conclusion, ctDNA and CTC are correlated and both have poor prognostic significance. CTC detection can be performed in every patient but, in patients with detectable mutations, ctDNA was more frequently detected than CTC and has possibly more prognostic value.
  • International journal of cancer. Journal international du cancer.Int J Cancer.2014 Mar 1;134(5):1207-13. doi: 10.1002/ijc.28436. Epub 2013 Sep 3.
  • Circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) have been recently investigated in several cancer types, but their respective clinical significance remains to be determined. In our prospective study, we compared the detection rate and the prognostic value of these two circulating bi
  • PMID 23934701
  • tRNA gene copy number variation in humans.
  • Iben JR1, Maraia RJ2.Author information 1Intramural Research Program on Genomics of Differentiation, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, USA.2Intramural Research Program on Genomics of Differentiation, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, USA. Electronic address: maraiar@mail.nih.gov.AbstractThe human tRNAome consists of more than 500 interspersed tRNA genes comprising 51 anticodon families of largely unequal copy number. We examined tRNA gene copy number variation (tgCNV) in six individuals; two kindreds of two parents and a child, using high coverage whole genome sequence data. Such differences may be important because translation of some mRNAs is sensitive to the relative amounts of tRNAs and because tRNA competition determines translational efficiency vs. fidelity and production of native vs. misfolded proteins. We identified several tRNA gene clusters with CNV, which in some cases were part of larger iterations. In addition there was an isolated tRNALysCUU gene that was absent as a homozygous deletion in one of the parents. When assessed by semiquantitative PCR in 98 DNA samples representing a wide variety of ethnicities, this allele was found deleted in hetero- or homozygosity in all groups at ~50% frequency. This is the first report of copy number variation of human tRNA genes. We conclude that tgCNV exists at significant levels among individual humans and discuss the results in terms of genetic diversity and prior genome wide association studies (GWAS) that suggest the importance of the ratio of tRNALys isoacceptors in Type-2 diabetes.
  • Gene.Gene.2014 Feb 25;536(2):376-84. doi: 10.1016/j.gene.2013.11.049. Epub 2013 Dec 14.
  • The human tRNAome consists of more than 500 interspersed tRNA genes comprising 51 anticodon families of largely unequal copy number. We examined tRNA gene copy number variation (tgCNV) in six individuals; two kindreds of two parents and a child, using high coverage whole genome sequence data. Such d
  • PMID 24342656
  • Ion sensing (EIS) real-time quantitative monitorization of isothermal DNA amplification.
  • Veigas B, Branquinho R, Pinto JV, Wojcik PJ, Martins R, Fortunato E, Baptista PV.Author information CIGMH, Departamento de Ciências da Vida, Faculdade de Ciências e Tecnologia, Universidade Nova de Lisboa, Campus de Caparica, 2829-516 Caparica, Portugal; CENIMAT/I3N, Departamento de Ciência dos Materiais, Faculdade de Ciências e Tecnologia, Universidade Nova de Lisboa and CEMOP-UNINOVA, Campus de Caparica, 2829-516 Caparica, Portugal.AbstractField-effect-based devices are becoming a basic structural element in a new generation of microbiosensors. Reliable molecular characterization of DNA and/or RNA is of paramount importance for disease diagnostics and to follow up alterations in gene expression profiles. The use of such devices for point-of-need diagnostics has been hindered by the need of standard or real-time PCR amplification procedures. The present work focuses on the development of a tantalum pentoxide (Ta2O5) based sensor for the real-time label free detection of DNA amplification via loop mediated isothermal amplification (LAMP) allowing for quantitative analysis of the cMYC proto-oncogene. The strategy based on the field effect sensor was tested within a range of 1 × 10(8)-10(11) copies of target DNA, and a linear relationship between the log copy number of the initial template DNA and threshold time was observed allowing for a semi-quantitative analysis of DNA template. The concept offers many of the advantages of isothermal quantitative real-time DNA amplification in a label free approach and may pave the way to point-of-care quantitative molecular analysis focused on ease of use and low cost.
  • Biosensors & bioelectronics.Biosens Bioelectron.2014 Feb 15;52:50-5. doi: 10.1016/j.bios.2013.08.029. Epub 2013 Aug 24.
  • Field-effect-based devices are becoming a basic structural element in a new generation of microbiosensors. Reliable molecular characterization of DNA and/or RNA is of paramount importance for disease diagnostics and to follow up alterations in gene expression profiles. The use of such devices for po
  • PMID 24021655

和文文献

  • DITAを利用した企業向け人材育成教材作成モデルの構想
  • 高橋 慈子,今村 誠
  • 情報処理学会研究報告. DD, [デジタル・ドキュメント] 2013-DD-88(3), 1-8, 2013-01-11
  • 企業向け人育成教材は,講師用と受講生用,受講者の習熟度別, 1 日コース・ 2 日コースなどの研修長さ別,そして,説明用スライドと配布用資料など,対象者,用途,コースなどに応じて少しずつ異なる教材を作成するという特徴がある.これらの教材作成では,現状はで Office などの文書やスライド作成ツールを使うことが多いので,対象者や用途に応じて異なる部分の編集ではカット&ペーストをする必要が生じるため …
  • NAID 110009509314
  • コピー機消耗品需給における需要と在庫の変化対応策 (特集 これからのIE的課題)
  • 教授就任記念講演 ゲノム・エピゲノム異常を指標とするがんと遺伝疾患関連遺伝子探索研究
  • 井本 逸勢
  • 四国医学雑誌 = Shikoku acta medica 68(5・6), 211-216, 2012-12-25
  • NAID 40019553372
  • 「画の六法」と写実についての一考察
  • 松永 拓己,マツナガ タクミ,Matsunaga Takumi
  • 熊本大学教育学部紀要 人文科学 61, 193-203, 2012-12-12
  • … 1Qiyuu shengdong 気韻生動, 2Technique of an outline and a brush, 3About a form, 4About a color, 5About composition, 6The copy of a masterpiece. …
  • NAID 120005199516

関連リンク

Sync, protect, and share your files - A simple cloud solution ...
これ本当に凄いんです.簡単に言うと「無料で大容量使えるDropbox」。そんなCopyの魅力、ダウンロード/インストール方法、使い方、お得情報などを超シンプルに...
注釈 COPYは通常のテーブルに対してのみ使用することができます。 ビューに対して使用することはできません。 しかし、COPY (SELECT * FROM viewname) TO ...と記述することができます。 COPYは指定された特定のテーブルのみを ...

関連画像

icons button document copy document copy 128x128pxadvertisementcopyGot Answer From: http://www.techterms.com Digital GlossaryCopy and paste: Is it this easy?before i left for rsa two weeks ago i had


★リンクテーブル★
リンク元duplicate」「reproduction」「reproduce」「replicate」「replica
拡張検索light microscopy」「biomicroscopy」「electronmicroscopy
関連記事cop」「coping」「copying

duplicate」

  [★]

  • adj.
  • 複製する、重複させる
  • n.
copyduplicationoverlapredundantlyreplicatereplicationreplicationalreplicativereproducereproduction

WordNet   license wordnet

「make a duplicate or duplicates of; "Could you please duplicate this letter for me?"」

WordNet   license wordnet

「a copy that corresponds to an original exactly; "he made a duplicate for the files"」
duplication

PrepTutorEJDIC   license prepejdic

「(他のものと)『そっくり同じの』,『複製の』 / (同じようなものが)対になっている / (原物とそっくり同じ)『写し』,控え,複写,写本,複製[物](copy) / (2個同時に作製したものの)一方,(そっくり同じものの)片方,片割れ / 〈原本・原作など〉‘を'複写する,複製する / …‘を'そっくり模倣する / …‘を'2重(2倍)にする / 〈同じこと〉‘を'繰り返す」

WordNet   license wordnet

「being two identical」
matching, twin, twinned

WordNet   license wordnet

「make or do or perform again; "He could never replicate his brilliant performance of the magic trick"」
reduplicate, double, repeat, replicate

WordNet   license wordnet

「identically copied from an original; "a duplicate key"」


reproduction」

  [★]

  • n.
breedbreedingcopyduplicateduplicationgenerativegenitalmultiplyplaybackpropagatepropagationrecycleregenerateregenerationregrowregrowthrenaturationrenaturerenewrenewalreplicatereplicationreplicationalreplicativerepresentationreproducereproductivereproductive period

WordNet   license wordnet

「the sexual activity of conceiving and bearing offspring」
procreation, breeding, facts of life

WordNet   license wordnet

「the act of making copies; "Gutenberg''s reproduction of holy texts was far more efficient"」
replication

WordNet   license wordnet

「the process of generating offspring」

WordNet   license wordnet

「recall that is hypothesized to work by storing the original stimulus input and reproducing it during recall」
reproductive memory

PrepTutorEJDIC   license prepejdic

「〈U〉繁殖,生殖[作用] / 〈U〉(…を)再生(再現)すること;模写(複製)すること《+『of』+『名』》 / 〈C〉再生(再現)された物,複写(複製)した物」


reproduce」

  [★]

  • v.
  • 再現する、再生する、複製する、繁殖する
breedbreedingcopyduplicateduplicationmultiplyplaybackpropagatepropagationrecycleregenerateregenerationregrowregrowthrenaturationrenaturerenewrenewalreplicatereplicationreplicationalreplicativerepresentationreproduction

WordNet   license wordnet

「recreate a sound, image, idea, mood, atmosphere, etc.; "this DVD player reproduces the sound of the piano very well"; "He reproduced the feeling of sadness in the portrait"」

WordNet   license wordnet

「have offspring or produce more individuals of a given animal or plant; "The Bible tells people to procreate"」
procreate, multiply

PrepTutorEJDIC   license prepejdic

「〈場面など〉‘を'『再現する』,〈音など〉‘を'再生する / …‘を'『複製する』,『複写する』 / 〈動物が〉〈子孫〉‘を'生む,〈植物が〉〈同類〉‘を'繁殖させる / 〈動植物が〉繁殖する / 〈芸術作品などが〉複製(再生)できる」

WordNet   license wordnet

「make a copy or equivalent of; "reproduce the painting"」


replicate」

  [★]

  • v.
  • 複製する、再現する、反復した
  • n.
copyduplicateduplicationiterationrecursionreiteratereiterationreiterativerepeatrepeatedlyrepetitionrepetitiverepetitivelyreplicationreplicationalreplicativerepresentationreproducereproduction

WordNet   license wordnet

「reproduce or make an exact copy of; "replicate the cell"; "copy the genetic information"」
copy

PrepTutorEJDIC   license prepejdic

「(統計)実施・(楽)1[数]オクターブ高い[低い]音・(葉などが)折返った・反復した・再生する・ 模写[複製]する; 折返す.〈葉など〉‘を'折り返す,曲げ返す・…‘を'繰り返す・細胞分裂で再生する」


replica」

  [★]

  • n.
copy

WordNet   license wordnet

「copy that is not the original; something that has been copied」
replication, reproduction

PrepTutorEJDIC   license prepejdic

「(原作者が作った)原作の写し / 模写,複製(copy),模型」


light microscopy」

  [★]

  • n.
light microscopemicroscopy


biomicroscopy」

  [★] 生体顕微鏡

in vivo microscopein vivo microscopyIVM



electronmicroscopy」

  [★]

electron microscopy


cop」

  [★]

PrepTutorEJDIC   license prepejdic

「警官,ポリ公」

PrepTutorEJDIC   license prepejdic

「…'を'捕らえる」


coping」

  [★] コーピング

PrepTutorEJDIC   license prepejdic

「(へい・手すりなどの上に置く)かさ石,かさ木」


copying」

  [★]

WordNet   license wordnet

「an act of copying」


"http://meddic.jp/copy" より作成


★コメント★

[メモ入力エリア]
※コメント5000文字まで
ニックネーム:
コメント:




表示
個人用ツール


  meddic.jp

リンク
連絡
週間・日々の人気記事
最近7日間の人気記事
 タイトル表示
1マーフィー徴候 18
2narrow segment 16
3" wounds are made"  15
4グレイ症候群 15
5"phenoxypolyethoxylethanol" 15
6ロイシンエンケファリン 13
7硝酸ミコナゾール 11
8Common Laboratory Equipment 11
9content 10
10だいすいたいしんけい 9
11粟粒結核と肉下種 9
12全身性ヒマン細胞小 9
13細胞内寄生菌 9
14kligler培地 原理 9
15不整脈  9
16角膜反射 中枢 9
17膜性骨化 8
18ソルデム 8
19ハプロ不全 疾患 8
20日本多毛 8

昨日の人気記事
 タイトル表示
1" wounds are made"  15
2kligler培地 原理 9
3kligler培地 硫化鉄 4
4ǸCαꥦ륹ΤǤ뤳ȤŦƤ֤Ƥ 4
5歳の女性。右目の疼痛、充血および霧視を主訴に来院した。眼底に異常を認めない。視力は右 0.9 (矯正不能)、左 1.2 (矯正不能)。眼圧は右 11 mmHg、左 12 mmHg。フルオレセイン染色後の前眼部写真 (別冊No. 5) を別に示す。 治療薬として適切なのはどれか。 4
6胃癌 borrmann分類 3
7回復過程 3
8ジェンドラシック法 メカニズム 3
9しょうすいたいしんけい 3
10ラリンゲルマスク ゼリー 3
11ハッセルバッハ三角 3
12白内障 grade 3
13フォンギールケ病 3
14マッコーネルサイン 3
15小児骨折 好発部位 3
16咽頭神経叢 3
17低アルドステロン症 3
18フロマン徴候 3
19オーグメンチン 販売中止 3
20クスマウル徴候 3